BioElectronics Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
28.60
45.30
144.40
5.80
8.90
92.90
Total Accounts Receivable
120.30
234.50
254.30
121.40
22.80
64.70
Inventories
716.90
393.30
593.90
581.20
441.20
295
Other Current Assets
-
-
-
-
27.20
15.50
Total Current Assets
865.80
673.20
992.60
708.40
500.10
468.10
Net Property, Plant & Equipment
25.10
19.40
8.50
5.20
3.00
0.80
Total Assets
890.90
692.60
1,001.10
713.70
503.10
469
ST Debt & Current Portion LT Debt
2,002.50
2,622.60
4,947.40
5,109.10
4,617.20
Accounts Payable
681.60
482.40
648.40
697.40
951.10
Other Current Liabilities
124.00
18.00
141.90
9.70
26.10
Total Current Liabilities
2,808.10
3,123.00
5,737.70
5,816.20
5,594.30
Long-Term Debt
5,623.50
5,718.00
4,118.70
4,658.70
5,593.20
Total Liabilities
8,431.60
8,841.00
9,856.30
10,474.90
11,187.50
Common Equity (Total)
7,540.70
8,148.30
8,855.30
9,761.20
10,684.40
Total Shareholders' Equity
7,540.70
8,148.30
8,855.30
9,761.20
10,684.40
Total Equity
7,540.70
8,148.30
8,855.30
9,761.20
10,684.40
Liabilities & Shareholders' Equity
890.90
692.60
1,001.10
713.70
503.10

About BioElectronics

View Profile
Address
4539 Metropolitan Court
Frederick Maryland 21704
United States
Employees -
Website http://www.bioelectronicscorp.com
Updated 07/08/2019
BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. Its products include ActiPatch, Allay, Smart Insole, HealFast, and RecoveryRx. The company was founded by Andrew J.